Sûreté des injections

Sanofi Pasteur Announces Publication of Positive Data for Fluzone High-Dose Vaccine in the New England Journal of Medicine

Sanofi Pasteur, the vaccines division of Sanofi, today announced that The New England Journal of Medicine published positive results from a large-scale, multi-center efficacy trial, which found that Fluzone® High-Dose (Influenza Vaccine) was more efficacious in preventing influenza (“the flu”) in adults 65 years of age and older compared to standard-dose Fluzone vaccine.
 
Undefined

West Africa Ebola outbreak tops 2,000 infections

The Ebola virus disease (EVD) illness total in West Africa's outbreak has pushed past 2,000, as the World Health Organization (WHO) tempered expectations that experimental drugs and vaccines will play a role in ending the event and providing a bird's eye view of response activities, including food drops in quarantined areas.
 
Undefined

NewLink Genetics Claims Most Advanced Ebola Vaccine Candidate

NewLink Genetics, an American pharmaceutical company based in Ames, Iowa will be continuing work on an Ebola vaccine candidate that has already been proven to be effective in primates.
 
Although the company usually focuses on cancer research, it announced that the the United States Defense Threat Reduction Agency has granted them a contract to bring the Ebola vaccine closer to human clinical trials.
 
Undefined

L’OMS convoque des experts pour un examen éthique du traitement expérimental contre le virus Ebola

Au début de la semaine prochaine, l’OMS convoquera un tableau d’experts en matière d’éthique médicale pour étudier la possibilité de recourir à un traitement expérimental dans le cadre de la flambée de virus Ebola en cours en Afrique de l’Ouest. Il n’existe actuellement aucun médicament ou vaccin homologué contre ce virus, mais plusieurs options expérimentales sont en cours de mise au point.
 
Undefined

Considérations éthiques liées à l’utilisation d’interventions non homologuées contre la maladie à virus Ebola

L’Afrique de l’Ouest est en train de subir la flambée de virus Ebola la plus étendue, la plus sévère et la plus complexe enregistrée dans l’histoire. Les flambées de cette maladie peuvent être contenues en mettant en œuvre des interventions disponibles comme le dépistage et l’isolement précoces des cas, la recherche et le suivi des contacts et le respect de procédures rigoureuses de lutte contre l’infection. Néanmoins, disposer d’un traitement ou d’un vaccin spécifique serait un atout puissant pour contrer le virus Ebola.
 
Undefined

Robert Kennedy Jr.’s belief in autism-vaccine connection, and its political peril

Sen. Barbara Mikulski listened impassively as Robert Kennedy Jr. made his case. He had to talk over the din in the marbled hallway just outside the Senate chambers, where he was huddled with Mikulski, two of her aides and three allies of his who had come to Washington for this April meeting.
 
Undefined

Fœtus : Une découverte scientifique vers des vaccins in utero ?

Les lymphocytes T des fœtus actifs et fonctionnels
 
Les chercheurs ont annoncé dans un communiqué datant du 10 juin 2014 que les fœtus disposent d’un système immunitaire actif contrairement aux recherches précédentes. En effet, les fœtus détiennent un stock de lymphocytes T. Mais auparavant, ils étaient persuadés que ces lymphocytes T restaient inactifs si aucune pathologie infectieuse ne survenait durant la grossesse.
 
Undefined

Combining vaccines may help eradicate polio

Combining two types of polio vaccine, including one that is injected rather than given orally, appears to give better immunity and could speed efforts to eradicate the crippling disease, scientists said on Friday.
 
British and Indian researchers said the inactivated polio vaccine (IPV), which is given by injection, could provide better and longer lasting protection if given alongside the more commonly used live oral polio vaccine (OPV).
 
Undefined

FDA approves 2014-2015 formulation of Flublok influenza vaccine

Protein Sciences Corp. announced on Tuesday that the U.S. Food and Drug Administration approved the company’s strain change amendment to Flublok, its seasonal influenza vaccine, for the 2014-2015 flu season.
 
Influenza vaccine manufacturers must receive approval from the FDA for any changes made to their manufacturing processes or product formulation. The early approval for Flublok will ensure that healthcare providers will receive the vaccine on time for the flu season in the fall.
 
Undefined

HPV Vaccine Cleared Of Link To Blood Clotting

Study shows no link between HPV vaccine and Blood Clotting
 
Undefined

Pages